Fertin and Perrigo take on US nicotine gum players
US drugmaker Perrigo has started selling a new nicotine gum to help smokers quit the habit in the US, challenging the dominance there of Pfizer and GlaxoSmithKline's Nicorette product.
US drugmaker Perrigo has started selling a new nicotine gum to help smokers quit the habit in the US, challenging the dominance there of Pfizer and GlaxoSmithKline's Nicorette product.
Finnish chemicals company Kemira is planning to buy Verdugt BV of the Netherlands in a move that will triple its sales of organic acids at a stroke and make it the number one company in the sector.
Hungary's Richter Gedeon reported rises in both overall sales and profits in 2004, although its active pharmaceutical ingredient (API) business remained under pressure in the US.